GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (OTCPK:ARSUF) » Definitions » Other Long Term Assets

ARSUF (Fagron) Other Long Term Assets : $40.7 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Fagron Other Long Term Assets?

Fagron's other long-term assets for the quarter that ended in Dec. 2024 was $40.7 Mil.

Fagron's quarterly other long-term assets declined from Dec. 2023 ($43.8 Mil) to Jun. 2024 ($37.9 Mil) but then increased from Jun. 2024 ($37.9 Mil) to Dec. 2024 ($40.7 Mil).

Fagron's annual other long-term assets declined from Dec. 2022 ($48.7 Mil) to Dec. 2023 ($43.8 Mil) and declined from Dec. 2023 ($43.8 Mil) to Dec. 2024 ($40.7 Mil).


Fagron Other Long Term Assets Historical Data

The historical data trend for Fagron's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fagron Other Long Term Assets Chart

Fagron Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 28.17 30.52 48.73 43.83 40.71

Fagron Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.73 45.60 43.83 37.94 40.71

Fagron Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Fagron Business Description

Traded in Other Exchanges
Address
Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies that are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America, and Fagron Latin America. The majority of its revenue comes from Fagron North America.

Fagron Headlines

From GuruFocus

Fagron NV At Capital Markets Day Transcript

By GuruFocus Research 02-12-2024

Q4 2022 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2022 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Q4 2023 Fagron NV Earnings Call Transcript

By GuruFocus Research 03-25-2024

Q2 2021 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2020 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Half Year 2020 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2022 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024